Domain Registration Corp (“BioPharm Asia, Inc”) Opens 360 New Drugstores in Jilin and Liaoning Provinces

SHENZHEN, China, June 12 /PRNewswire-Asia-FirstCall/ — Domain
Registration Corp. (OTC Bulletin Board: DOMR), today announces that the
Company (in the process of changing its name to “BioPharm Asia Inc.”) has
opened 360 new drugstores in Jilin and Liaoning Provinces, through its
subsidiary Tonghua Shengantang Medical & Pharmacy Company Limited. A majority
of the 360 chain drugstores are strategically located in the following areas:
Tonghua, Jilin, Changchun, Siping and Yanji in Jilin Province, as well as
Dalian in Liaoning Province.

With the implementation of universal healthcare reforms and the continuous
improvement of rural medical services in China, the second-tier and third-tier
cities, towns and counties will begin receiving comprehensive medical coverage.
Likewise, increases in disposable income throughout the rural population have
accelerated the urbanization of these relatively more developed areas. At the
same time, widespread chain store retailing is becoming more accepted in the
rural markets, and “BioPharm Asia” is poised to take advantage of their
increasingly dense population and purchasing power, especially in Jilin and
Liaoning Provinces.

“The successful addition of 360 new drugstores constitutes a major step in
improving BioPharm Asia’s consumer reach and achieving distribution wide
economies of scale,” said Yunlu Yin, Chief Executive Officer. “By continuing
to open new drugstores in target distribution markets like Jilin and Liaoning
Provinces, BioPharm Asia is aggressively penetrating these pharmaceutical
markets and appealing to China’s rising middle class by catering directly to
its rural medical needs.”

About Domain Registration Corp (“BioPharm Asia, Inc.”)

In the process of changing its corporate name to “BioPharm Asia, Inc.”,
the Company is primarily engaged in the retail sale of medical products in
China, complemented by a series of integrated business segments that include
the cultivation of Chinese herbal medicines, pharmaceutical production and
wholesale medicine distribution. Following several successful acquisitions
through China Northern Pharmacy Holding Group Limited, the Company has
preliminarily completed the integration of its distribution channels,
expanding its trading business (which includes chain stores, distribution and
wholesale business) to include pharmaceutical manufacturing and cultivation of
medicinal raw materials. For more information, please visit
http://www.biopharmasiainc.com .

Forward-looking statement: Except for the historical information, the
matters discussed in this news release may contain forward-looking statements,
including, but not limited to, factors relating to future sales. These
forward-looking statements may involve a number of risks and uncertainties.
Actual results may differ materially based on a number of factors, including,
but not limited to, uncertainties in product demand, risks related to doing
business in China, the impact of competitive products and pricing, changing
economic conditions around the world, release and sales of new products and
other risk factors detailed in the company’s most recent annual report and
other filings with the Securities and Exchange Commission.

    For more information, please contact:

     Domain Registration Corp ("BioPharm Asia, Inc.")
     Lijun Zhang
     Tel:   +1-718-705-4217
     Email: vp@biopharmasiaco.com

SOURCE Domain Registration Corp (“BioPharm Asia, Inc.”)